Form 8-K - Current report:
SEC Accession No. 0001860782-24-000106
Filing Date
2024-10-31
Accepted
2024-10-31 07:08:17
Documents
13
Period of Report
2024-10-31
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20241031.htm   iXBRL 8-K 26567
  Complete submission text file 0001860782-24-000106.txt   155172

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20241031.xsd EX-101.SCH 1891
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20241031_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20241031_pre.xml EX-101.PRE 13144
15 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20241031_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 241412403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)